|
SMYD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.66133814775094E-16 |
| Normal-vs-Stage2 |
3.22060000002011E-06 |
| Normal-vs-Stage3 |
2.05613304160579E-12 |
| Normal-vs-Stage4 |
4.9800163992586E-12 |
| Stage1-vs-Stage2 |
1.426570E-01 |
| Stage1-vs-Stage3 |
5.517700E-02 |
| Stage1-vs-Stage4 |
7.438300E-02 |
| Stage2-vs-Stage3 |
9.016500E-03 |
| Stage2-vs-Stage4 |
1.298030E-02 |
| Stage3-vs-Stage4 |
7.466400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.73404999999072E-05 |
| Normal-vs-Asian |
1.56680000085174E-08 |
| Caucasian-vs-AfricanAmerican |
5.674400E-01 |
| Caucasian-vs-Asian |
6.138200E-01 |
| AfricanAmerican-vs-Asian |
8.671800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.06168415672892E-12 |
| Normal-vs-Female |
8.79496475647557E-12 |
| Male-vs-Female |
7.837400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.53299620062353E-11 |
| Normal-vs-Age(41-60Yrs) |
2.79776202205539E-14 |
| Normal-vs-Age(61-80Yrs) |
2.24043006369357E-12 |
| Normal-vs-Age(81-100Yrs) |
5.040000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.790400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.856200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.058000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.761400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.033600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.607000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.846800E-04 |
| Classical-VS-Follicular |
1.175400E-01 |
| Classical-VS-Other |
8.640400E-01 |
| Classical-VS-Normal |
5.90979487569143E-11 |
| Tall-VS-Follicular |
1.370470E-04 |
| Tall-VS-Other |
2.595200E-01 |
| Tall-VS-Normal |
5.51780843238703E-14 |
| Follicular-VS-Other |
7.550400E-01 |
| Follicular-VS-Normal |
1.6563999949426E-08 |
| Other-VS-Normal |
7.498600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.54951656745106E-15 |
| Normal-vs-N1 |
2.28583818540073E-12 |
| N0-vs-N1 |
1.304280E-02 |
|
|
